{
  "type": "ref",
  "text": "FGF2-stimulated microvessel formation was inhibited by sequestration of FGF2 via addition of soluble FGF receptor (FGFR) chimera protein or anti-FGF2 antibodies.\n",
  "self": {
    "NER": {
      "answers": [
        "FGF",
        "FGFR"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the soluble FGF receptor?",
          "What is the chimera protein that inhibits FGF2?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "FGF2-stimulated microvessel formation",
        "sequestration",
        "FGF2",
        "addition",
        "soluble FGF receptor",
        "(FGFR) chimera protein",
        "anti-FGF2 antibodies"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was inhibited by sequestration of FGF2?",
          "What inhibited FGF2?",
          "What was sequestered by adding soluble FGF receptor chimera protein?",
          "What inhibited microvessel formation?",
          "What does FGFR stand for?",
          "What is the soluble FGF receptor?",
          "What was used to inhibit FGF2-stimulated microvessel formation?"
        ]
      }
    }
  },
  "asked": {
    "What was evaluated by monitoring tumor growth and microvessel formation?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00864630937576294,
        "ground_truth": {
          "The antitumor activity": {
            "bertscore": 0.66721111536026,
            "f1": 0
          }
        }
      }
    },
    "What antitumor drug was tested in SCC7 tumors?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.005071759223937988,
        "ground_truth": {
          "cRGD-HL": {
            "bertscore": 0.6345595121383667,
            "f1": 0
          }
        }
      }
    },
    "What was monitored in SCC7?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.005064427852630615,
        "ground_truth": {
          "tumor growth": {
            "bertscore": 0.6900307536125183,
            "f1": 0
          }
        }
      }
    },
    "What was the antitumor activity of cRGD-HL monitored for?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0007842779159545898,
        "ground_truth": {
          "microvessel formation": {
            "bertscore": 0.6838944554328918,
            "f1": 0
          }
        }
      }
    },
    "What was the primary tumor that was monitored?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0011808276176452637,
        "ground_truth": {
          "squamous cell carcinoma (SCC7) tumor": {
            "bertscore": 0.5756173729896545,
            "f1": 0
          }
        }
      }
    }
  }
}